BioNTech

The plant is expected to start producing 50 million vaccines, but the production will increase depending on the demand. Senegal’s President Macky Sall arrived in Rwanda on Sunday evening ahead of the inauguration of BioNTech Africa, a cutting-edge manufacturing facility for mRNA-based vaccines, on Monday, December 18. President Sall was received by Minister of Finance and Economic Planning Uzziel Ndagijimana at the Kigali International Airport. Earlier on Sunday, the Senegalese Presidency posted a tweet on…